R107474

DB06553ExperimentalSmall molecule

Investigated for use/treatment in depression.

Mechanism: Pharmacologically active on Alpha-2A adrenergic receptor, Alpha-2C adrenergic receptor, and Alpha-2B adrenergic receptor
Curator reviewed
Primary indication: Investigated for use/treatment in depression.Curator reviewed
Formula / weight: C₂₂H₂₁N₃O₂ · 359.429 g/mol (avg)
Also known as: 3-(2-(3,4-Dihydrobenzofuro(3,2-c)pyridin-2(1H)-yl)ethyl)-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one · 3-[2-(3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one · Lusaperidone
Code names: CS-7154 · DA-75161 · G13590 · HY-U00117 · MS-25665 · R107474

Resolves to

Compound

Structure

InChIKeyZYXHQIPQIKTEDI-UHFFFAOYSA-NSMILESCC1=C(CCN2CCC3=C(C2)C2=C(O3)C=CC=C2)C(=O)N2C=CC=CC2=N1

Targets

What you can answer from here — as of July 03, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with R107474, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.